相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
Hee Jin Lee et al.
JOURNAL OF CLINICAL PATHOLOGY (2016)
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
Kimberly J. Briggs et al.
CELL (2016)
Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy
Mahima Swamy et al.
NATURE IMMUNOLOGY (2016)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
R. Salgado et al.
ANNALS OF ONCOLOGY (2015)
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer
Sung Gwe Ahn et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
Sylvia Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen et al.
NATURE (2014)
Targeting T cell immunometabolism for cancer immunotherapy; understanding the impact of the tumor microenvironment
Mary B. Mockler et al.
FRONTIERS IN ONCOLOGY (2014)
Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer
Sewha Kim et al.
ENDOCRINE-RELATED CANCER (2013)
Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis
Pallavi Chaturvedi et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
Sherene Loi et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Analysis of glutamine dependency in non-small cell lung cancer GLS1 splice variant GAC is essential for cancer cell growth
A. Pieter et al.
CANCER BIOLOGY & THERAPY (2012)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Glutamine Synthetase Is a Genetic Determinant of Cell Type-Specific Glutamine Independence in Breast Epithelia
Hsiu-Ni Kung et al.
PLOS GENETICS (2011)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Jian-Bin Wang et al.
CANCER CELL (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
R. J. DeBerardinis et al.
ONCOGENE (2010)
Glutamine addiction: a new therapeutic target in cancer
David R. Wise et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
M. Elizabeth H. Hammond et al.
JOURNAL OF ONCOLOGY PRACTICE (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
Chendong Yang et al.
CANCER RESEARCH (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
Ping Gao et al.
NATURE (2009)
Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity
Mohan R. Kaadige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Cancer cell metabolism: Warburg and beyond
Peggy P. Hsu et al.
CELL (2008)
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
David R. Wise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Mariia Yuneva et al.
JOURNAL OF CELL BIOLOGY (2007)
分享论文
